Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |